Granted Patent
B2
US 10,995,354 · App. 16/165,372 · Granted May 4, 2021
Modification of RNA-related enzymes for enhanced production
Inventors:
Bettina Strack-Logue (Lexington, MA); Frank DeRosa (Lexington, MA); Michael Heartlein (Lexington, MA)
Assignee:
Translate Bio, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides, among other things, methods and compositions for large-scale production of capped mRNA using SUMO-Guanylyl Transferase fusion protein.
Claims (3)
1. A fusion protein, wherein the fusion protein comprises guanylyl transferase and a small ubiquitin-like molecule (SUMO) protein, wherein the fusion protein comprises SEQ ID NO: 8 and SEQ ID NO: 7.
2. The fusion protein of claim 1 , wherein the guanylyl transferase comprises a large subunit and a small subunit.
3. The fusion protein of claim 2 , wherein the SUMO protein is covalently linked and co-expressed with the large subunit.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 19, 2018
From: STRACK-LOGUE, BETTINA; DEROSA, FRANK; HEARTLEIN, MICHAEL
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 047237/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 19, 2018
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: RANA THERAPEUTICS, INC.
Reel/Frame 047273/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 19, 2018
From: RANA THERAPEUTICS, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 047872/0767 →
Continuity (3)
Provisional Application
62241350
· Oct 14, 2015
Cited By (1)